Variability of patterns of fatigue and quality of life over time based on different breast cancer adjuvant chemotherapy regimens

Oncology Nursing Forum

Volumn 36, Issue 5, 2009, Pages 563-570

  Berger, Ann M ^b   Lockhart, Kari ^b   Agrawal, Sangeeta ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; TAXOID;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FATIGUE; FEMALE; HUMAN; LONGITUDINAL STUDY; MIDDLE AGED; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTHRACYCLINES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; EPIRUBICIN; FATIGUE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; QUALITY OF LIFE; TAXOIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 75749095782     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/09.ONF.563-570     Document Type: Article

References (27)

1. American Cancer Society. (2007). Cancer facts and figures 2007. Retrieved September 22, 2007, from http://www.cancer.org/down loads/STT/ CAFF2007PWSecured.pdf
2. American Cancer Society. (2009). Cancer facts and figures 2009. Retrieved July 27, 2009, from http://www.cancer.org/downloads/ STT/500809web.pdf
3. Andrykowski, M.A., Schmidt, J.E., Salsman, J.M., Beacham, A.O., & Jacobsen, P.B. (2005). Use of a case definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. Journal of Clinical Oncology, 23(27), 6613-6622. (Pubitemid 46190255)
4. Avis, N.E., Crawford, S., & Manuel, J. (2005). QOL among younger women with breast cancer. Journal of Clinical Oncology, 23(15), 3322-3330.
5. Banthia, R., Malcarne, V.L., Roesch, S.C., Ko, C.M., Greenbergs, H.L., Varni, J.W., et al. (2006). Correspondence between fatigue reports in breast cancer survivors. Journal of Behavioral Medicine, 29(3), 269-279. (Pubitemid 43800853)
6. Berger, A.M., Kuhn, B.R., Farr, L.A., Lynch, J.C., Agrawal, S., Chamberlain, J., et al. (2009). Behavioral therapy intervention trial to improve sleep quality and cancer-related fatigue. Psycho-Oncology, 18(6), 634-646.
7. Berger, A.M., Sankaranarayanan, J., & Watanabe-Galloway, S. (2007). Current methodological approaches to the study of sleep disturbances and QOL in adults with cancer. Psycho-Oncology, 16(5), 401-420. (Pubitemid 46844641)
8. Box, B.A., & Russell, C.A. (2004). Breast cancer. In D.A. Casciato (Ed.), Manual of clinical oncology (5th ed., pp. 233-253). Philadelphia: Lippincott Williams and Wilkins.
9. Byar, K.L., Berger, A.M., Bakken, S.L., & Cetak, M.A. (2006). Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life [Online exclusive]. Oncology Nursing Forum, 33(1), E18-E26. Retrieved July 20, 2009, from http://ons.metapress.com/ content/um1281005428t806/fulltext. pdf
10. Cleeland, C.S., Mendoza, T.R., Wang, X.S., Chou, C., Harle, M.T., Morrissey, M., et al. (2000). Assessing symptom distress in cancer patients: The M.D. Anderson Symptom Inventory. Cancer, 7(89), 1634-1646.
11. de Jong, N., Courtens, A.M., Abu-Saad, H.H., & Schouten, H.C. (2002). Fatigue in patients with breast cancer receiving adjuvant chemotherapy. Cancer Nursing, 25(4), 283-297. (Pubitemid 34815439)
12. Haghighat, S., Akbari, M.E., Holakouei, K., Rahimi, A., & Montazeri, A. (2003). Factors predicting fatigue in breast cancer patients. Supportive Care in Cancer, 11(8), 533-538. (Pubitemid 36994437)
13. Heidrich, S.M., Egan, J.J., Hengudomsub, P., & Randolph, S.M. (2006). Symptoms, symptom beliefs, and quality of life of older breast cancer survivors. Oncology Nursing Forum, 33(2), 315-322. (Pubitemid 43672485)
14. Martin, M., Lluch, A., Segui, M.A., Ruiz, A., Ramos, M., Adrover, E., et al. (2006). Toxicity and health-related quality of life in breast cancer pa- tients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC): Impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen. Annals of Oncology, 17(8), 1205-1212. (Pubitemid 44288210)
15. Mills, P.J., Parker, B., Dimsdale, J.E., Robins-Sadler, G.R., & Ancoli- Israel, S. (2005). The relationship between fatigue and quality of life and inflammation during anthracycline-based chemotherapy in breast cancer. Biological Psychology, 69(1), 85-96. (Pubitemid 40299384)
16. Mitchell, S.A., Beck, S.L., Hood, L.E., Moore, K., & Tanner, E.R. (2007). Putting evidence into practice: Evidence-based interventions for fatigue during and following cancer and its treatment. Clinical Journal of Oncology Nursing, 11(1), 99-113.
17. Moulder, S., & Hortobagyi, G.N. (2008). Advances in the treatment of breast cancer. Clinical Pharmacology and Therapeutics, 83(1), 26-36.
18. National Comprehensive Cancer Network. (2008a). NCCN Clinical Practice Guidelines in Oncology™: Cancer-related fatigue [v.1.08]. Retrieved February 23, 2008, from http://www.nccn.org/profes sionals/physician-gls/PDF/ fatigue.pdf
19. National Comprehensive Cancer Network. (2008b). NCCN Clinical Practice Guidelines in Oncology™: Invasive breast cancer [v.1.08]. Retrieved September 4, 2008, from http://www.nccn.org/profes sionals/physician-gls/PDF/ breast.pdf
20. Piper, B.F., Dibble, S.L., Dodd, M.J., Weiss, M.C., Slaughter, R.E., & Paul, S.M. (1998). The Revised Piper Fatigue Scale: Psychometric evaluation in women with breast cancer. Oncology Nursing Forum, 25(4), 677-684.
21. Piper, B.F., Lindsey, A.M., & Dodd, M.J. (1987). Fatigue mechanisms in cancer patients. Oncology Nursing Forum, 14(6), 17-23.
22. Prue, G., Rankin, J., Allen, J., Gracey, J., & Cramp, F. (2006). Cancer-related fatigue: A critical appraisal. European Journal of Cancer, 42(7), 846-863.
23. Sura, W., Murphy, S.O., & Gonzales, I. (2006). Level of fatigue in women receiving dose-dense versus standard chemotherapy for breast cancer: A pilot study. Oncology Nursing Forum, 33(5), 1015-1021.
24. Ware, J.E. (2000). SF-36 Health Survey. Spine, 25(24), 3130-3139.
25. Wielgus, K.K., Berger, A.M., & Hertzog, M. (2009). Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy. Oncology Nursing Forum, 36(1), 38-48.
26. Wildiers, H., Dirix, L., Neven, P., Prove, A., Clement, P., Squifflet, P., et al. (2009). Delivery of adjuvant sequential dose-dense FEC-Doc to patients with breast cancer is feasible, but dose reductions and toxicity are dependent on treatment. Breast Cancer Treatment Research, 114(1), 103-112.
27. Woo, B., Dibble, S.L., Piper, B.F., Keating, S.B., & Weiss, M.C. (1998). Differences in fatigue by treatment methods in women with breast cancer. Oncology Nursing Forum, 25(5), 915-920.